GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bora Pharmaceuticals Co Ltd (TPE:6472) » Definitions » Debt-to-Asset

Bora Pharmaceuticals Co (TPE:6472) Debt-to-Asset : 0.42 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bora Pharmaceuticals Co Debt-to-Asset?

Bora Pharmaceuticals Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$3,909 Mil. Bora Pharmaceuticals Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$15,070 Mil. Bora Pharmaceuticals Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was NT$45,599 Mil. Bora Pharmaceuticals Co's debt to asset for the quarter that ended in Dec. 2024 was 0.42.


Bora Pharmaceuticals Co Debt-to-Asset Historical Data

The historical data trend for Bora Pharmaceuticals Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bora Pharmaceuticals Co Debt-to-Asset Chart

Bora Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.30 0.33 0.20 0.42

Bora Pharmaceuticals Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.30 0.43 0.43 0.42

Competitive Comparison of Bora Pharmaceuticals Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Bora Pharmaceuticals Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bora Pharmaceuticals Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bora Pharmaceuticals Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bora Pharmaceuticals Co's Debt-to-Asset falls into.


;
;

Bora Pharmaceuticals Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bora Pharmaceuticals Co's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3909.334 + 15069.854) / 45598.934
=0.42

Bora Pharmaceuticals Co's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3909.334 + 15069.854) / 45598.934
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bora Pharmaceuticals Co  (TPE:6472) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Bora Pharmaceuticals Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bora Pharmaceuticals Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bora Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Aly. 36, Lane 26, Ruiguang Road, 6th Floor, Neihu District, Taipei, TWN, 114
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Commercial sales segment, Contract Development & Manufacturing Organization segment, and Other segment. The majority of revenue is derived from the Commercial sales segment. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.

Bora Pharmaceuticals Co Headlines

No Headlines